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Obesity, Diet, Physical Activity, and Health-Related Quality of
Life in Endometrial Cancer Survivors
Dimitrios A. Koutoukidis, M. Tish Knobf, and Anne Lanceley
Obesity, low-quality diet, and inactivity are all prevalent among survivors of endo-
metrial cancer. The present review was conducted to assess whether these charac-
teristics are associated with health-related quality of life (HRQoL). Electronic
databases, conference abstracts, and reference lists were searched, and researchers
were contacted for preliminary results of ongoing studies. The quality of the meth-
odology and reporting was evaluated using appropriate checklists. Standardized
mean differences were calculated, and data were synthesized narratively. Eight of
the 4385 reports retrieved from the literature were included in the analysis. Four of
the 8 studies were cross-sectional, 1 was retrospective, 1 was prospective, and 2
were randomized controlled trials. Obesity was negatively associated with overall
HRQoL in 4 of 4 studies and with physical well-being in 6 of 6 studies, while it was
positively associated with fatigue in 2 of 4 studies. Meeting the recommendations for
being physically active, eating a diet high in fruit and vegetables, and abstaining
from smoking were positively associated with overall HRQoL in 2 of 2 studies, with
physical well-being in 2 of 3 studies, and with fatigue in 1 of 3 studies.
Improvements in fatigue and physical well-being were evident after lifestyle inter-
ventions. The ﬁndings indicate a healthy lifestyle is positively associated with HRQoL
in this population, but the number of studies is limited. Additional randomized con-
trolled trials to test effective and practical interventions promoting a healthy lifestyle
in survivors of endometrial cancer are warranted.
INTRODUCTION
Endometrial cancer is the fourth most common cancer
in women in the United Kingdom. Each year, more
than 7000 cases are diagnosed,1,2 Endometrial cancer
has one of the highest survival rates; 75% of diagnosed
women are likely to survive for at least 10 years.1
Given these data, research on the survivorship popula-
tion is of considerable importance.
Endometrial cancer survivors experience decreased
health-related quality of life (HRQoL), primarily due to
cancer and its treatment.3 Other factors, however, like
lifestyle behaviors, may also play a role. Evidence from
the general cancer survivorship literature suggests that
meeting nutritional and physical activity recommenda-
tions is positively associated with HRQoL.4 A recent
Cochrane review indicated that exercise interventions
significantly improve HRQoL in cancer survivors.5
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Nevertheless, there is a high prevalence of low physical
activity, poor dietary quality, and obesity among endo-
metrial cancer survivors,6 many of whom demonstrate
low physical fitness levels7 and have persistent and
long-term treatment effects like fatigue6 and mild bowel
injury symptoms.8 These conditions and persistent
treatment-related symptoms have been associated with
poorer HRQoL in this population.
Despite the robust evidence regarding the effects of
diet, physical activity, and obesity on endometrial can-
cer risk,9 data on these factors and outcomes for survi-
vors of endometrial cancer are limited. The purpose of
this review is to explore the associations of obesity
(body mass index [BMI], body composition), diet (food
groups, dietary patterns), and physical activity with
HRQoL in survivors of endometrial cancer.
LITERATURE SEARCH METHODS
Eligibility criteria
The population of interest included survivors of endo-
metrioid carcinoma stages I–IV.10,11 Due to differences
in morphology and prognosis, clear cell or papillary se-
rous carcinomas as well as sarcomas were excluded.12
Survivors were defined as those surviving after the end
of primary or adjuvant therapy treatment with or with-
out recurrent disease. Studies investigating the associa-
tions of obesity, diet, and physical activity with HRQoL
in survivors of endometrial cancer were eligible (see
Appendix S1 available in the Supporting Information
for this article online). Inclusion was limited to studies
that reported a measure of the effect or association be-
tween the variables and HRQoL.
Assessment of HRQoL. HRQoL was conceptually de-
fined as subjective assessments of physical well-being
and symptoms (e.g., functional activities, fatigue, pain),
social well-being (e.g., family distress, work), psycholog-
ical well-being (e.g., anxiety, depression), and spiritual
well-being (e.g., uncertainty, hope).13 A conceptual defi-
nition was used because there is no commonly accepted
definition of HRQoL, though it is broadly accepted to
be a multidimensional, self-rated measure of well-being.
The questionnaires most commonly used to assess
HRQoL are the European Organization for Research and
Treatment of Cancer Core Questionnaire (EORTC
QLQ-C30),14 the Functional Assessment for Cancer
Therapy–General (FACT-G),15 and the Short-Form 36-
Item Health Survey (SF-36).16 These are standardized
tools, and a comparison of their characteristics is shown
in Table 1. The physical, emotional, and functional sub-
scales of the EORTC QLQ-C30 and the FACT-G are suf-
ficiently similar to allow direct comparisons.17 The same
applies to the physical functioning, emotional function-
ing/mental health, and pain subscales of the EORTC
QLQ-C30 and SF-36.18 The correlations between the
FACT-G physical well-being score and the SF-36 physi-
cal composite score as well as between the FACT-G emo-
tional well-being score and the SF-36 mental composite
Table 1 Characteristics of the three questionnaires commonly used to assess health-related quality of life
Characteristic FACT-G (27 items) EORTC QLQ-C30 (30 items) SF-36 (36 items)
Overall structure 4 scales of well-being 5 scales of functioning and 9 scales of
symptoms
7 scales of functioning and 1 scale
of symptoms, clustered in 2
composite scores
Scaling
Well-being scales Functional scales Physical health
Physical well-being (7 items) Physical functioning (5 items) Physical functioning (10 items)
Functional well-being (7 items) Role functioning (2 items) Role physical (4 items)
Emotional well-being (6 items) Emotional functioning (4 items) Bodily pain (2 items)
Social/family well-being (7 items) Social functioning (2 items) General health (5 items)
Symptoms Cognitive functioning (items) Mental health
Fatigue (13 items)a Symptom scales/items Role emotional (3 items)
Anemia (7 items)a Fatigue (3 items) Social functioning (2 items)
Pain (2 items) Mental health (5 items)
Nausea and vomiting (2 items) Vitality (4 items)
Dyspnea, insomnia, constipation,
diarrhea, appetite loss, ﬁnancial
difﬁculties (1 each)
Overall score (27 items) Global health status/QoL (2 items)
Item delivery Statements Questions Both questions and statements
Response options Likert scales with 5 options Likert scales with 4 or 7 options Likert scales with 3, 5, or 6 options
Yes/no questions
Recall period Past 7 days Past week Past 4 weeks
Abbreviations: EORTC QLQ-C30, European Organization for Research and Treatment of Cancer Core Questionnaire; FACT-G, Functional
Assessment for Cancer Therapy–General; QoL, quality of life; SF-36, Short-Form 36-Item Health Survey.
aAdditional subscales in the FACT-G. Not counted in the overall score of FACT-G but counted in the overall score of FACIT-F (Functional
Assessment for Chronic Illness Therapy-Fatigue) and/or FACT-An (anemia).
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score are also strong.19 Thus, the operational definition
of HRQoL included overall HRQoL, 4 well-being
domains (physical, functional, emotional, and social),
and 2 symptoms (fatigue and pain).
Identification of studies
Embase, MEDLINE via PubMed, Cochrane, and
PsycINFO databases were searched from database incep-
tion until January 2014, with no language restrictions.
Reference lists from included papers were scanned visu-
ally. The following websites were also included in the
search: World Health Organization International
Clinical Trials Registry Platform (www.who.int/ictrp/
en), Current Controlled Trials (www.controlled-trials.
com), and ClinicalTrials.gov (www.clinicaltrials.gov).
To identify unpublished literature, relevant conference
proceedings were searched manually, and experts were
contacted for preliminary results of ongoing studies. An
experienced academic librarian contributed to the search
protocol (see Appendix S2 in the Supporting
Information online), which included relevant terms for
the following domains: diet, energy balance, body com-
position, physical activity, fatigue, pain, HRQoL, and
physical, psychological, social, and spiritual well-being.
Study selection
One researcher (D.A.K.) reviewed the titles and abstracts
and, subsequently, the full texts of those references that
seemed to satisfy inclusion criteria. In the interest of time,
authors were not contacted. The team discussed potential
ambiguities before making a final decision on study inclu-
sion. Duplicate reports of any study were regarded as a
single study. Duplication was identified through sample
size, authorship, and methodology, and the most appro-
priate data sets were selected. If data from the primary pa-
pers could not be extracted, a secondary analysis of more
than 1 study was included in the analysis.
Data extraction
Data were extracted using EndNote X7 and Microsoft
Excel 2011. The guidelines from the Centre for Reviews
and Dissemination20 were followed to generate the data
extraction forms (Appendix S3 available in the
Supporting Information online).
Quality assessment
Methodological quality was assessed through the
Scottish Intercollegiate Guidelines Network (SIGN)
checklists.21 Quality of reporting was based on the
Strengthening the Reporting of Observational Studies
in Epidemiology (STROBE) guidelines for observational
studies22 and the Consolidated Standards of Reporting
Trials (CONSORT) statement for clinical trials.23 Data
on quality assessment of the cohorts and trials are avail-
able in Appendix S4 in the Supporting Information
online.
Data synthesis. As only 2 randomized controlled trials
(RCTs) were identified, the data were synthesized narra-
tively.24 Studies were clustered primarily by outcome
measures. To allow comparisons between different
measurement tools and sample sizes, standardized
mean differences (effect sizes) were produced by
calculating Cohen’s d [d¼ (mean1 – mean2)/SDpooled] be-
tween nonobese (i.e., normal-weight and overweight)
and obese (all categories) subjects and between those
meeting guidelines (as defined in the papers) and those
who did not. In order for data from Blanchard et al.
(2010)25 to be included in the analysis, the obese and
nonobese groups in the study were assumed to be of
equal size. Fatigue and pain scales were corrected for di-
rectional differences, so that all scales have the same di-
rection. Standardized mean differences were defined as
small if d¼ 0.2, medium if d¼ 0.5, and large if d¼ 0.8.26
RESULTS
In total, 4382 records were identified. Of those, 12 re-
ports of 8 studies were included in the final analysis.
The flowchart (Figure 1) shows the study selection pro-
cess and the reasons for exclusion. Four of the 8 studies
were cross-sectional, 1 was retrospective, 1 was prospec-
tive, and 2 were RCTs. The evaluation tools most widely
used were the EORTC QLQ-C30, the SF-36, and the
FACT-G.
Table 24,27–29 shows the 4 studies that assessed
overall HRQoL. Three were cross-sectional and 1 was
retrospective. Two used the SF-36, 1 the EORTC, and 1
the FACT instrument, but all showed similar patterns
of improved HRQoL with lower BMI and healthier life-
style behaviors. Specifically, 3 studies assessed the im-
pact of BMI on HRQoL. Two of them found small to
medium differences of 0.21 (0.04–0.37) and 0.29
(0.01–0.59) on HRQoL between the nonobese and
obese groups,28,29 and 1 found large differences (0.75
[0.54–0.96]).27 The last study showed an improved gen-
eral HRQoL with lower BMI and increased physical ac-
tivity after adjusting for major confounders.
Furthermore, there was a large size difference of 0.78
(0.30–1.26) in HRQoL in survivors who met the physi-
cal activity guidelines, consumed 5 servings of fruits
and vegetables per day, and abstained from smoking.4
Effect sizes regarding HRQoL domains and symp-
toms are shown in Table 3.4,6,25,27–31 Better scores for
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physical well-being were universally demonstrated in
the nonobese groups, but with wide variability that
ranged from small to large effect sizes. Two of the 3
studies found significantly better physical well-being
scores27,30 in those meeting the physical activity guide-
lines, with the magnitude of difference being medium
to large. Marginally better scores or nonsignificant
trends toward them were demonstrated for functional
well-being in nonobese and physically active survivors.
Emotional well-being was slightly better in 1 of 5
studies in nonobese subjects29 and was nonsignificantly
better in the rest. There was a trend toward better emo-
tional well-being in those who met the physical activity
goals (0.14 [0.07 to 0.36])27 and in those who met 2 of
the 3 health behavior recommendations compared with
those who did not (0.45 [0.15 to 1.05]).6 Small signifi-
cant differences in social well-being between BMI cate-
gories were reported in 2 of 4 studies.
Furthermore, findings for nonobese and physically
active survivors showed either a nonsignificant trend or
significantly lower fatigue scores of a medium effect size
(0.28–0.54), apart from 1 study that reported slightly
increased fatigue in nonobese subjects (0.04 [0.33 to
0.41]).30 Finally, pain was lower in the nonobese groups,
with the difference between the nonobese and the obese
groups ranging from 0.11 to 0.47, and scores
showing a medium size difference (0.52 [0.97 to
0.07]) in favor of the physically active group in 1
study.30
Data from the 2 clinical trials on lifestyle interven-
tions for weight loss (Table 432–35) partly support the
prospective, retrospective, and cross-sectional data on
HRQoL domains and symptoms. Only 1 of these trials
showed a significant difference in fatigue after 3 months
(P¼ 0.008) and in physical functioning after 6 months
(P¼ 0.048).32 However, neither of these trials was statis-
tically powered to detect differences in quality of life, and
both may suffer from selection bias, as many participants
were following relatively healthy lifestyles. Their method-
ological quality was scored as acceptable32 or low.34
DISCUSSION
Both obesity and the failure to meet guidelines for
healthy lifestyle behaviors were negatively associated
with HRQoL. Associations were stronger for the
HRQoL domain of physical well-being and a subscale
measure of fatigue. Overall, the effect sizes, although
limited and for which wide standard deviations were
found, are of a magnitude similar to that in the general
population36 and in survivors of different types of can-
cer, such as breast, prostate, and colorectal.4,37,38 This
Id
en
tif
ic
at
io
n 
Sc
re
en
in
g
In
cl
ud
ed
 
El
ig
ib
ili
ty
 
 4382 records identified 
through database 
searching 
3 additional records 
identified through other 
sources 
65 records after duplicates removed 
4320 records 
screened
4153 records 
excluded
167 full-text articles 
assessed for eligibility 
12 records included in 
synthesis 
155 full-text articles 
excluded 
Reviews: 11 
No relevant association / 
not reporting an 
association: 126 
Not endometrial cancer: 
12 
Prevention / Incidence / 
Risk: 7 
Figure 1 Flowchart of the literature search and selection process
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further strengthens the hypothesis that maintaining a
healthy lifestyle by being physically active, meeting die-
tary guidelines, abstaining from smoking, and main-
taining a healthy weight correlates with an improved
quality of life in this group of cancer patients. However,
as most of the studies reviewed were cross-sectional,
causality cannot be inferred.
The current results are consistent with a meta-anal-
ysis of cancer survivors who demonstrated an improved
quality of life following exercise interventions.5
Although a recent analysis showed that attaining desir-
able exercise levels might be unlikely in cancer survi-
vors, behavioral interventions showed an improvement
in aerobic capacity,39 a strong predictor of mortality.40
Given the low physical fitness levels of endometrial can-
cer survivors7 and findings that indicate only small
changes are needed to provide substantial health bene-
fits,41 facilitating the physical activity levels of this pop-
ulation is imperative. Furthermore, exercise seems to
ameliorate cancer-related fatigue,42 although this type
of fatigue may be driven more by dysfunctions of the
central nervous system than by abnormal muscle me-
tabolism (as in malnutrition-related fatigue).43 Further
mechanistic studies can provide insight on this.
It would have been desirable, but was not possible,
to establish dose-response relationships. However,
many studies4,27–29 indicated a tendency toward an in-
verse association between unhealthy lifestyle and
Table 3 Effect of exposure variables on health-related quality of life (HRQoL) domains and symptoms
Reference HRQoL measure Standardized mean difference (95%CI); d¼ (mean1–mean2)/SDpooled
BMI (nonobese vs obese) Physical activity (met vs did not
meet guidelines)
Physical well-being
Courneya et al. (2005)27 FACT-G PWB 0.19 (0.01–0.40) 0.43 (0.21–0.65)
von Gruenigen et al. (2011)6 a FACT-G PWB – 0.16 (0.43 to 0.75)b
Fader et al. (2011)31 c FACT G PWB 0.81 (0.40–1.23) –
Smits et al. (2013)29 EORTC QLQ-C30 PF 0.45 (0.15–0.74) –
Oldenburg et al. (2013)28 SF-36 PF 0.76 (0.59–0.93) –
Basen-Engquist et al. (2009)30 SF-36 PF 0.66 (0.28–1.04) 0.86 (0.40–1.32)
Blanchard et al. (2010)25 SF-36 PHc 0.44 (0.20–0.69) –
Functional well-being
Courneya et al. (2005)27 FACT-G FWB 0.05 (0.16 to 0.26) 0.26 (0.04–0.48)
von Gruenigen et al. (2011)6 a FACT-G FWB – 0.35 (0.25 to 0.95)b
Fader et al. (2011)31 c FACT-G FWB 0.19 (0.22 to 0.60) –
Smits et al. (2013)29 EORTC QLQ-C30 RF 0.31 (0.01–0.60) –
Emotional well-being/mental health
Courneya et al. (2005)27 FACT-G EWB 0.06 (0.14 to 0.27) 0.14 (0.07 to 0.36)
von Gruenigen et al. (2011)6 a FACT-G EWB – 0.45 (0.15 to 1.05)b
Fader et al. (2011)31 c FACT-G EWB 0.12 (0.28 to 0.53) –
Smits et al. (2013)29 EORTC QLQ-C30 EF 0.25 (0.09–0.42) –
Oldenburg et al. (2013)28 SF-36 MHs 0.12 (0.04 to 0.29) –
Blanchard et al. (2010)25 SF-36 MHc 0.16 (0.09 to 0.40) –
Social well-being
Courneya et al. (2005)27 FACT-G SWB 0.20 (0.01 to 0.41) 0.33 (0.23–0.33)
Fader et al. (2011)31 c FACT-G SWB 0.30 (0.14–0.46) –
Oldenburg et al. (2013)28 SF-36 SF 0.12 (0.05–0.20) –
Smits et al. (2013)29 EORTC QLQ-C30 SF 0.25 (0.05 to 0.54) –
Fatigue
Courneya et al. (2005)27 FACIT-F 0.42 (0.62 to 0.21) 0.40 (0.61 to 0.18)
von Gruenigen et al. (2011)6 a FACIT-F – 0.54 (1.14 to 0.06)b
Smits et al. (2013)29 EORTC QLQ-C30 F 0.28 (0.58 to 0.01) –
Oldenburg et al. (2013)28 FAS 0.34 (0.50 to 0.17) –
Basen-Engquist et al. (2009)30 BFI 0.04 (0.33 to 0.41) 0.44 (0.89 to 0.01)
Pain
Basen-Engquist et al. (2009)30 BPI 0.11 (0.48 to 0.26) 0.52 (0.97 to 0.07)
Smits et al. (2013)29 EORTC QLQ-C30 P 0.30 (0.59 to 0.01) –
Oldenburg et al. (2013)28 SF-36 BP 0.47 (0.64 to 0.31) –
Abbreviations: BFI, Brief Fatigue Inventory; BP, bodily pain; BPI, Brief Pain Inventory; EF, emotional functioning; EWB, emotional well-being;
EORTC QLQ-C30, European Organization for Research and Treatment of Cancer Core Questionnaire; FACIT-F, Functional Assessment of
Chronic Illness Therapy–Fatigue; FACIT-G, Functional Assessment of Chronic Illness Therapy–General; FAS, Fatigue Assessment Survey;
FWB, functional well-being; MHc, mental health composite score; MHs, mental health score; P, pain; PF, physical function, PHc, physical
composite score; PWB, physical well-being; RF, role-functional; SF, social functioning; SF-36, Short-Form 36-Item Health Survey; SWB, social
well-being.
aSecondary analysis of McCarroll et al.,32 von Gruenigen et al.34
bMeeting either 5-a-day and no smoking or 150min/wk and no smoking.
cSecondary analysis of McCarroll et al.32 von Gruenigen et al.34 von Gruenigen et al.67
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HRQoL assessments, which seems consistent among
survivors of different types of cancer.4 No clear evi-
dence of an association between body composition and
HRQoL, or of the effects of diet on HRQoL, has been
described. Objective body composition and serum bio-
marker measurements had been pre-specified in the
protocol of the SUCCEED trial.32 A future report from
the trial may provide further insight into the nutritional
status of endometrial cancer survivors, given that cen-
tral adiposity is a stronger predictor of mortality in
women than BMI.44
Regarding weight loss, it is generally accepted that
unintentional weight loss is a clear risk factor for a worse
prognosis. Unfortunately, the scarcity of data does not al-
low firm conclusions about intentional weight loss in en-
dometrial cancer survivors. However, valid points can be
drawn from the largest trials in other cancer survivors
and from the broad body of literature on obese older
adults. The literature from the general obese elderly pop-
ulation strongly supports that HRQoL – especially physi-
cal function – and cardiometabolic risk factors will be
improved by a lifestyle intervention that involves weight
loss; moreover, the side effects of such an intervention
are minor.45–47 The underlying mechanisms are beyond
the scope of this discussion but have been previously
documented.48 Evidence from cancer survivors supports
the benefits for physical function following a 1-year
home-based weight loss, diet-and-exercise interven-
tion.49 Importantly, adherence to the lifestyle interven-
tion strongly correlated with HRQoL outcomes in cancer
survivors,50 and ceasing the intervention reduced the
beneficial effects of lifestyle interventions.49,51 Survivors
of early-stage endometrial cancer do not experience a
high burden of symptoms29 and are most likely to die
from cardiovascular disease long after their cancer diag-
nosis.52 Although the results of large-scale weight-loss in-
terventions in breast cancer survivors are still awaited,53
these findings indicate that intentional weight loss might
be beneficial in survivors of early-stage endometrial can-
cer, particularly if it incorporates physical activity that
includes resistance training.
As far as can be determined, this is the first report
of an association between HRQoL and obesity, diet, and
physical activity in endometrial cancer survivors. The
review was conducted following the PRISMA guide-
lines,54 but given the broad scope of the review, inter-
vention and comparison criteria were not prespecified.
A comprehensive search strategy was used to identify
potential studies. Although the results are based only on
published data, future studies should adhere to guide-
lines for quality of reporting. No study reported objec-
tive measures of physical activity. Most studies used
self-reported, validated questionnaires, which are prone
to recall and social desirability bias.
Despite the discrepancy in the scales of the HRQoL
instruments – the FACT-G measures well-being, whereas
the EORTC QLQ-C30 and SF-36 measure functional as-
sessments – the similarity of most of the scales is suffi-
cient to allow direct comparisons to be made, as
indicated in the discussion of assessment of HRQoL be-
low. The nonsignificant results in the social well-being
category are not very informative, primarily because of
the important differences among the instruments used to
measure this scale.55 To eliminate the effects of each in-
strument, standardized mean differences were calculated
where possible. Importantly, the observed differences are
based on subjective assessments and, therefore, rely on
the individual’s perceptions of the level of each scale they
experience, which may vary among individuals. While
Cohen’s effect sizes determine statistically significant dif-
ferences, they seem to correlate well with clinical signifi-
cance.56 Thus, the medium size differences in overall
HRQoL, physical well-being, and fatigue may be cau-
tiously interpreted as clinically important differences that
can guide implementation of interventions and policy
decisions. Even the small size differences may be impor-
tant because of the large population of endometrial can-
cer survivors and the high prevalence of obesity and
unhealthy lifestyle among them.
Findings may not be generalizable because of the
lack of sociodemographic data reporting. Given the
high level of education and lack of ethnic diversity
among participants in studies that collected such data,
the results may not apply to the broader population of
endometrial cancer survivors, who are often of low so-
cioeconomic level.1
Implications for practice and research
Future research should address the longitudinal effect of
weight control, exercise, and diet after a diagnosis of en-
dometrial cancer and should examine the potential effects
on HRQoL. In light of funding constraints, HRQoL, an
indicator of survival,57 could be a valuable alternative
method of evaluating prognosis, but this remains to be
elucidated in endometrial cancer survivors affected
mostly by early-stage disease, since evidence from breast
cancer survivors suggests that HRQoL is predictive of sur-
vival in advanced-stage, but not early-stage, disease.57
Interventions targeting more representative samples
of cancer survivors can increase the generalizability of
the findings. Behavior change can be challenging, how-
ever, due to socioeconomic and environmental bar-
riers,58 which include restricted access to recreational
facilities and the increased cost of healthier diets. Further
challenges include cancer-related effects like fatigue, lim-
ited social support, lack of motivation, and uncertainty
about the effects of diet.58–60 Self-monitoring, social
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support, practice, and rewards are effective in improving
physical activity when incorporated into lifestyle inter-
ventions.61 Contrarily, the relevant effectiveness of tech-
niques to achieve dietary change is more obscure, given
the inaccuracy of dietary reporting in most trials.62 Self-
efficacy about weight management improved following
lifestyle interventions in survivors of early-stage endome-
trial32 and other cancers.63
While data are limited in this population, it is rea-
sonable to speculate that sarcopenia, and even cachexia,
could be prevalent.64 These conditions add significantly
to the mortality burden of obesity.65 Accordingly, fur-
ther research should extend to anthropometric indices
other than BMI, like waist-to-height ratio, handgrip
strength, and body composition analysis, and should
also focus on the effects of resistance training and a
plant-based, protein-sufficient diet. Notably, interven-
tions should be supported by appropriate policy ac-
tions66 in order to be efficacious.
CONCLUSION
The data, while predominantly cross-sectional, indicate
that overall HRQoL and physical well-being are posi-
tively correlated with adherence to lifestyle recommen-
dations, while fatigue is negatively associated with
adherence. Future RCTs should evaluate health behav-
ior change interventions (determining the safety, fre-
quency, duration, intensity, and delivery mode) in
endometrial cancer survivors.
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